|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar
|
|
3
|
Huang JY, Xu YY, Sun Z, et al: Comparison
different methods of intraoperative and intraperitoneal
chemotherapy for patients with gastric cancer: a meta-analysis.
Asian Pac J Cancer Prev. 13:4379–4385. 2012. View Article : Google Scholar
|
|
4
|
Meyer HJ and Wilke H: Treatment strategies
in gastric cancer. Dtsch Arztebl Int. 108:698–705. 2011.
|
|
5
|
Bang YJ, Van Cutsem E, Feyereislova A, et
al: Trastuzumab in combination with chemotherapy versus
chemotherapy alone for treatment of HER2-positive advanced gastric
or gastro-oesophageal junction cancer (ToGA): a phase 3,
open-label, randomised controlled trial. Lancet. 376:687–697. 2010.
View Article : Google Scholar
|
|
6
|
De Vita F, Giuliani F, Silvestris N, et
al: Current status of targeted therapies in advanced gastric
cancer. Expert Opin Ther Targets. 16(Suppl 2): S29–S34.
2012.PubMed/NCBI
|
|
7
|
Naik S, Dothager RS, Marasa J, Lewis CL
and Piwnica-Worms D: Vascular endothelial growth factor receptor-1
is synthetic lethal to aberrant beta-catenin activation in colon
cancer. Clin Cancer Res. 15:7529–7537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tyner JW, Deininger MW, Loriaux MM, et al:
RNAi screen for rapid therapeutic target identification in leukemia
patients. Proc Natl Acad Sci USA. 106:8695–8700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giamas G, Filipovic A, Jacob J, et al:
Kinome screening for regulators of the estrogen receptor identifies
LMTK3 as a new therapeutic target in breast cancer. Nat Med.
17:715–719. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stebbing J, Filipovic A, Ellis IO, et al:
LMTK3 expression in breast cancer: association with tumor phenotype
and clinical outcome. Breast Cancer Res Treat. 132:537–544. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Camargo MC, Goto Y, Zabaleta J, Morgan DR,
Correa P and Rabkin CS: Sex hormones, hormonal interventions, and
gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers
Prev. 21:20–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sheh A, Ge Z, Parry NM, et al:
17β-estradiol and tamoxifen prevent gastric cancer by modulating
leukocyte recruitment and oncogenic pathways in Helicobacter
pylori-infected INS-GAS male mice. Cancer Prev Res (Phila).
4:1426–1435. 2011.
|
|
13
|
Ryu WS, Kim JH, Jang YJ, et al: Expression
of estrogen receptors in gastric cancer and their clinical
significance. J Surg Oncol. 106:456–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu CY, Guo JL, Jiang ZN, et al: Prognostic
role of estrogen receptor alpha and estrogen receptor beta in
gastric cancer. Ann Surg Oncol. 17:2503–2509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deng H, Huang X, Fan J, et al: A variant
of estrogen receptor-α, ER-α36 is expressed in human gastric cancer
and is highly correlated with lymph node metastasis. Oncol Rep.
24:171–176. 2010.
|
|
16
|
Zhou J, Teng R, Xu C, et al:
Overexpression of ERα inhibits proliferation and invasion of MKN28
gastric cancer cells by suppressing β-catenin. Oncol Rep.
30:1622–1630. 2013.
|
|
17
|
Cho JY: Molecular diagnosis for
personalized target therapy in gastric cancer. J Gastric Cancer.
13:129–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gravalos C and Jimeno A: HER2 in gastric
cancer: a new prognostic factor and a novel therapeutic target. Ann
Oncol. 19:1523–1529. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jorgensen JT and Hersom M: HER2 as a
prognostic marker in gastric cancer - a systematic analysis of data
from the literature. J Cancer. 3:137–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Furukawa H, Iwanaga T, Koyama H and
Taniguchi H: Effect of sex hormones on the experimental induction
of cancer in rat stomach - a preliminary study. Digestion.
23:151–155. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lindblad M, Ye W, Rubio C and Lagergren J:
Estrogen and risk of gastric cancer: a protective effect in a
nationwide cohort study of patients with prostate cancer in Sweden.
Cancer Epidemiol Biomarkers Prev. 13:2203–2207. 2004.PubMed/NCBI
|
|
22
|
Chandanos E and Lagergren J: Oestrogen and
the enigmatic male predominance of gastric cancer. Eur J Cancer.
44:2397–2403. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gan L, He J, Zhang X, et al: Expression
profile and prognostic role of sex hormone receptors in gastric
cancer. BMC Cancer. 12:5662012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsuyama S, Ohkura Y, Eguchi H, et al:
Estrogen receptor beta is expressed in human stomach
adenocarcinoma. J Cancer Res Clin Oncol. 128:319–324. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang M, Pan JY, Song GR, Chen HB, An LJ
and Qu SX: Altered expression of estrogen receptor alpha and beta
in advanced gastric adenocarcinoma: correlation with prothymosin
alpha and clinicopathological parameters. Eur J Surg Oncol.
33:195–201. 2007. View Article : Google Scholar
|
|
26
|
Chandanos E, Rubio CA, Lindblad M, et al:
Endogenous estrogen exposure in relation to distribution of
histological type and estrogen receptors in gastric adenocarcinoma.
Gastric Cancer. 11:168–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kitaoka H: Chemo-endocrine therapy of
diffuse carcinoma of the stomach and its clinical evaluation. Jpn J
Cancer Clinics. 31(Suppl 9): 1189–1194. 1985.(In Japanese).
|
|
28
|
Harrison JD, Morris DL, Ellis IO, Jones JA
and Jackson I: The effect of tamoxifen and estrogen receptor status
on survival in gastric carcinoma. Cancer. 64:1007–1010. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kojima O and Takahashi T: Endocrine
therapy of scirrhous carcinoma of the stomach. Jpn J Cancer
Chemother. 13:2526–2531. 1986.(In Japanese).
|
|
30
|
Kitaoka H: Sex hormone dependency in
diffuse carcinoma of the stomach and results of chemo-endocrine
therapy. Jpn J Cancer Clinics. 30(Suppl 6): 741–748. 1984.(In
Japanese).
|
|
31
|
Kim MJ, Cho SI, Lee KO, Han HJ, Song TJ
and Park SH: Effects of 17β-estradiol and estrogen receptor
antagonists on the proliferation of gastric cancer cell lines. J
Gastric Cancer. 13:172–178. 2013.
|
|
32
|
Shi H, Wu J, Ji M, et al: Serum lemur
tyrosine kinase 3 expression in colorectal cancer patients predicts
cancer progression and prognosis. Med Oncol. 30:7542013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wakatsuki T, LaBonte MJ, Bohanes PO, et
al: Prognostic role of lemur tyrosine kinase-3 germline
polymorphisms in adjuvant gastric cancer in Japan and the United
States. Mol Cancer Ther. 12:2261–2272. 2013. View Article : Google Scholar : PubMed/NCBI
|
